Solvonis Therapeutics (SVNS)

Sector:

Pharma and Biotech

0.30p
   
  • Change Today:
      0.005p
  • 52 Week High: 0.36
  • 52 Week Low: 0.12
  • Currency: UK Pounds
  • Shares Issued: 6,262m
  • Volume: 20,267,564
  • Market Cap: £18.47m

Broker Views

Show broker recommendations:
Show broker actions:
Date Broker name New Price Old price target New price target Broker change
14-Jun-22 Berenberg Bank Buy 16.05p - 0.22p Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

SVNS Market Data

Currency UK Pounds
Share Price 0.30p
Change Today 0.005p
% Change -1.67 %
52 Week High 0.36
52 Week Low 0.12
Volume 20,267,564
Shares Issued 6,262m
Market Cap £18.47m

SVNS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
44.36% below the market average44.36% below the market average44.36% below the market average44.36% below the market average44.36% below the market average
6.98% below the sector average6.98% below the sector average6.98% below the sector average6.98% below the sector average6.98% below the sector average
Price Trend
31.97% above the market average31.97% above the market average31.97% above the market average31.97% above the market average31.97% above the market average
24.44% above the sector average24.44% above the sector average24.44% above the sector average24.44% above the sector average24.44% above the sector average
Income Not Available
Growth Not Available

SVNS Dividends

No dividends found

Trades for 05-Aug-2025

Time Volume / Share Price
09:23 200,000 @ 0.30p
09:00 300,500 @ 0.30p
09:00 500 @ 0.30p
09:00 1 @ 0.30p
09:00 299,999 @ 0.30p

SVNS Key Personnel

CEO Anthony Tennyson
Chair Dennis Purcell
Finance Director Ryan Neats

Top of Page